You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Nvidia customers in the US and the Middle East expect that the newly introduced A100 servers will accelerate research into the novel coronavirus.
Facing questions over data security in the US and Ireland, the company has changed its name as it looks to shed its China operations.
Because of coronavirus-related shutdowns of customer labs, the San Diego-based firm saw decreased revenues in all geographic regions, especially outside the US.
The INFORM study echoed the 2019 interim results from the NCI Pediatric MATCH trial, which found that 24 percent of participants were eligible for targeted treatment.
Fresh off a new investment round, the British firm seeks to help research labs and biopharma companies manage population-level genomics research.
Because of COVID-19, the San Diego-based firm said it was unable to ship new instruments and many users were unable to operate their existing ones.
The research suggests that pangolins are natural hosts of Betacoronaviruses but does not support the idea that SARS-CoV-2 emerged directly from pangolins.
Launched last month as part of the EU's coronavirus action plan, the portal will collect and distribute SARS-CoV-2 sequencing and patient phenotype data.
With its second offering in less than a year, the AI and analytics company will apply as much as $487,000 to repay debts.
The San Diego-based genomics technology firm recognized Q1 revenues of $859 million, compared to $846 million in Q1 2019.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.